Inflammatory Myofibroblastic Tumors (DBCOND0054244)

Identifiers

Synonyms

Inflammatory Myofibroblastic Tumor / Inflammatory myofibroblastic tumour / Inflammatory pseudotumour / Inflammatory Pseudotumor / Inflammatory myofibroblastic tumor (disorder) / Myofibroblastic tumor (morphologic abnormality) / Inflammatory pseudotumor (morphologic abnormality) / Myofibroblastic tumor / Myofibroblastic tumour

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04260009	Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors	Brigatinib	treatment	1 / 2	withdrawn
NCT02180867	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	Cyclophosphamide Daunorubicin Doxorubicin Ifosfamide Pazopanib	treatment	2 / 3	active_not_recruiting
NCT04925609	Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors	Brigatinib	other	1 / 2	recruiting
NCT03874273	Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors	Crizotinib	treatment	2 / 3	unknown_status
NCT02465528	Ceritinib Rare Indications Study in ALK+ Tumors	Ceritinib	treatment	2	terminated
NCT03085186	Treatment With Crizotinib Single Patient Expanded Access IND 134375	Crizotinib	Not Available	Not Available	no_longer_available